Click for best price
Lung Cancer Therapy Market Size, Share 2022
This report contains market size and forecasts of Lung Cancer Therapy in Global, including the following market information:
Global Lung Cancer Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lung Cancer Therapy market was valued at 23730 million in 2021 and is projected to reach US$ 45650 million by 2028, at a CAGR of 9.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiation Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Therapy include GlaxoSmithKline, Menarini, Pfizer, Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Company and Abbott, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Therapy Market Segment Percentages, by Type, 2021 (%)
Radiation Therapy
Chemotherapy
Targeted Therapies
Immunotherapy
Global Lung Cancer Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Other
Global Lung Cancer Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lung Cancer Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lung Cancer Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Menarini
Pfizer
Roche
Merck
AstraZeneca
Sanofi-Aventis
Eli Lilly and Company
Abbott
Akebia Therapeutics
Agennix AG
| Report Attributes |
Report Details |
| Report Title |
Lung Cancer Therapy Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Therapy Overall Market Size
2.1 Global Lung Cancer Therapy Market Size: 2021 VS 2028
2.2 Global Lung Cancer Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Therapy Players in Global Market
3.2 Top Global Lung Cancer Therapy Companies Ranked by Revenue
3.3 Global Lung Cancer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lung Cancer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Lung Cancer Therapy Market Size Markets, 2021 & 2028
4.1.2 Radiation Therapy
4.1.3 Chemotherapy
4.1.4 Targeted Therapies
4.1.5 Immunotherapy
4.2 By Type - Global Lung Cancer Therapy Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Therapy Revenue, 2017-2022
4.2.2 By Type - Global Lung Cancer Therapy Revenue, 2023-2028
4.2.3 By Type - Global Lung Cancer Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Therapy Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Lung Cancer Therapy Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Therapy Revenue, 2017-2022
5.2.2 By Application - Global Lung Cancer Therapy Revenue, 2023-2028
5.2.3 By Application - Global Lung Cancer Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Lung Cancer Therapy Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Therapy Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Therapy Revenue, 2017-2022
6.2.2 By Region - Global Lung Cancer Therapy Revenue, 2023-2028
6.2.3 By Region - Global Lung Cancer Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Lung Cancer Therapy Revenue, 2017-2028
6.3.2 US Lung Cancer Therapy Market Size, 2017-2028
6.3.3 Canada Lung Cancer Therapy Market Size, 2017-2028
6.3.4 Mexico Lung Cancer Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Therapy Revenue, 2017-2028
6.4.2 Germany Lung Cancer Therapy Market Size, 2017-2028
6.4.3 France Lung Cancer Therapy Market Size, 2017-2028
6.4.4 U.K. Lung Cancer Therapy Market Size, 2017-2028
6.4.5 Italy Lung Cancer Therapy Market Size, 2017-2028
6.4.6 Russia Lung Cancer Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Lung Cancer Therapy Market Size, 2017-2028
6.4.8 Benelux Lung Cancer Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Therapy Revenue, 2017-2028
6.5.2 China Lung Cancer Therapy Market Size, 2017-2028
6.5.3 Japan Lung Cancer Therapy Market Size, 2017-2028
6.5.4 South Korea Lung Cancer Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Lung Cancer Therapy Market Size, 2017-2028
6.5.6 India Lung Cancer Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Lung Cancer Therapy Revenue, 2017-2028
6.6.2 Brazil Lung Cancer Therapy Market Size, 2017-2028
6.6.3 Argentina Lung Cancer Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Therapy Revenue, 2017-2028
6.7.2 Turkey Lung Cancer Therapy Market Size, 2017-2028
6.7.3 Israel Lung Cancer Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Lung Cancer Therapy Market Size, 2017-2028
6.7.5 UAE Lung Cancer Therapy Market Size, 2017-2028
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Lung Cancer Therapy Major Product Offerings
7.1.4 GlaxoSmithKline Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Menarini
7.2.1 Menarini Corporate Summary
7.2.2 Menarini Business Overview
7.2.3 Menarini Lung Cancer Therapy Major Product Offerings
7.2.4 Menarini Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.2.5 Menarini Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Lung Cancer Therapy Major Product Offerings
7.3.4 Pfizer Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Lung Cancer Therapy Major Product Offerings
7.4.4 Roche Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.4.5 Roche Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Lung Cancer Therapy Major Product Offerings
7.5.4 Merck Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.5.5 Merck Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Lung Cancer Therapy Major Product Offerings
7.6.4 AstraZeneca Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Sanofi-Aventis
7.7.1 Sanofi-Aventis Corporate Summary
7.7.2 Sanofi-Aventis Business Overview
7.7.3 Sanofi-Aventis Lung Cancer Therapy Major Product Offerings
7.7.4 Sanofi-Aventis Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.7.5 Sanofi-Aventis Key News
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporate Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Lung Cancer Therapy Major Product Offerings
7.8.4 Eli Lilly and Company Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.8.5 Eli Lilly and Company Key News
7.9 Abbott
7.9.1 Abbott Corporate Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Lung Cancer Therapy Major Product Offerings
7.9.4 Abbott Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.9.5 Abbott Key News
7.10 Akebia Therapeutics
7.10.1 Akebia Therapeutics Corporate Summary
7.10.2 Akebia Therapeutics Business Overview
7.10.3 Akebia Therapeutics Lung Cancer Therapy Major Product Offerings
7.10.4 Akebia Therapeutics Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.10.5 Akebia Therapeutics Key News
7.11 Agennix AG
7.11.1 Agennix AG Corporate Summary
7.11.2 Agennix AG Business Overview
7.11.3 Agennix AG Lung Cancer Therapy Major Product Offerings
7.11.4 Agennix AG Lung Cancer Therapy Revenue in Global Market (2017-2022)
7.11.5 Agennix AG Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Therapy Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Therapy Market Drivers in Global Market
Table 3. Lung Cancer Therapy Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Therapy in Global Market
Table 5. Top Lung Cancer Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lung Cancer Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lung Cancer Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lung Cancer Therapy Product Type
Table 9. List of Global Tier 1 Lung Cancer Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Lung Cancer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lung Cancer Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lung Cancer Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Lung Cancer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lung Cancer Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lung Cancer Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Lung Cancer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lung Cancer Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lung Cancer Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lung Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lung Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lung Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lung Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lung Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lung Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lung Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lung Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lung Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lung Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Lung Cancer Therapy Product Offerings
Table 32. GlaxoSmithKline Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Menarini Corporate Summary
Table 34. Menarini Lung Cancer Therapy Product Offerings
Table 35. Menarini Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Lung Cancer Therapy Product Offerings
Table 38. Pfizer Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Lung Cancer Therapy Product Offerings
Table 41. Roche Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Lung Cancer Therapy Product Offerings
Table 44. Merck Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Lung Cancer Therapy Product Offerings
Table 47. AstraZeneca Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi-Aventis Corporate Summary
Table 49. Sanofi-Aventis Lung Cancer Therapy Product Offerings
Table 50. Sanofi-Aventis Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly and Company Corporate Summary
Table 52. Eli Lilly and Company Lung Cancer Therapy Product Offerings
Table 53. Eli Lilly and Company Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Abbott Corporate Summary
Table 55. Abbott Lung Cancer Therapy Product Offerings
Table 56. Abbott Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Akebia Therapeutics Corporate Summary
Table 58. Akebia Therapeutics Lung Cancer Therapy Product Offerings
Table 59. Akebia Therapeutics Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Agennix AG Corporate Summary
Table 61. Agennix AG Lung Cancer Therapy Product Offerings
Table 62. Agennix AG Lung Cancer Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Lung Cancer Therapy Segment by Type in 2021
Figure 2. Lung Cancer Therapy Segment by Application in 2021
Figure 3. Global Lung Cancer Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Therapy Revenue in 2021
Figure 8. By Type - Global Lung Cancer Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lung Cancer Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lung Cancer Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lung Cancer Therapy Revenue Market Share, 2017-2028
Figure 12. US Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lung Cancer Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lung Cancer Therapy Revenue Market Share, 2017-2028
Figure 24. China Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lung Cancer Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lung Cancer Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lung Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Menarini Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi-Aventis Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly and Company Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbott Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Akebia Therapeutics Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Agennix AG Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
